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Introduction {#sec001}
============

Regenerative medicine using stem cells holds great promise for the treatment of some incurable diseases. In particular, mesenchymal stem cells (MSCs) \[[@pone.0236600.ref001]\] and induced pluripotent stem cells (iPSCs) \[[@pone.0236600.ref002]\] have been considered feasible cell sources. In recent years, many researchers have conducted clinical trials for developing new cell products \[[@pone.0236600.ref003]--[@pone.0236600.ref005]\]. In Japan, cell products are processed at each academic cell-processing facility (CPF) based on a new regulatory framework for regenerative medicine \[[@pone.0236600.ref006], [@pone.0236600.ref007]\]. The safety of cell products is threatened not only by undesired cell characteristics, such as tumorigenicity, but also by cell culture contamination caused by microorganisms. Sterilization is the simplest way to eliminate such infections; however, living cell products cannot be sterilized. Therefore, the most important aspect of cell processing safety is guaranteeing the sterility of the process.

The sterility of cell products is secured by the appropriate management of CPF environments and traceability based on these records. Such environmental management policy should be planned to depend on CPF structure to maintain proper cleanliness and eliminate the risk of extrinsic contamination of the process \[[@pone.0236600.ref008], [@pone.0236600.ref009]\]. The risk of extrinsic contamination can be affected by the location of the CPF, the environment inside or outside the CPF, and the degree of human intervention during the process \[[@pone.0236600.ref010], [@pone.0236600.ref011]\]. These environmental risk factors include temperature, humidity, number of particles, entrance time to a clean room, airborne microorganisms, and harmful insects. In Japan, the temperature and humidity fluctuate according to the season. Therefore, to perform an appropriate environmental risk assessment, it is essential to obtain total environmental data throughout the year. Since environmental factors may interact each other, the spatiotemporal relationships among them should be also evaluated.

The objective of this study was to assess the environmental risk factors inside and outside a CPF to guarantee the safety of cell products. We collected comprehensive environmental data throughout the year during an ongoing clinical study and investigated the relationships among them. Their effects on the sterility of processed cell products were also assessed.

Material & methods {#sec002}
==================

Classification of areas in the cell-processing facility (CPF) {#sec003}
-------------------------------------------------------------

The CPF was divided into uncontrolled and controlled areas ([Fig 1A](#pone.0236600.g001){ref-type="fig"}). The uncontrolled area was defined as the general environment (GE) and the controlled areas were divided into four areas (Grade D, Grade C, Grade B, and Grade A) according to cleanliness defined by "consideration on aseptic operation in cell culture processing facilities" based on the "Safety Act" published by the Japanese Society for Regenerative Medicine ([S1 Table](#pone.0236600.s004){ref-type="supplementary-material"}). Grade A was an area where aseptic operation was performed.

![Assessment items for each room of the Cell-Processing Facility (CPF).\
(a) Classification of areas in the CPF according to cleanliness defined by the Japanese Society for Regenerative Medicine ([S1 Table](#pone.0236600.s004){ref-type="supplementary-material"}). Assessed area is divided into uncontrolled and controlled areas. The uncontrolled area is defined as the general environment (GE), and the controlled areas are divided into four areas according to cleanliness. (b) Schematic diagram of CPF and assessment items in each room. Operators enter from the entrance, go through the first gowning room, the buffer room, and the second gowning room in that order, enter the cell-processing room, and work using a safety cabinet. The operators then pass through the de-gowning room, the buffer room, and the first gowning room before exiting. The colors represent the cleanliness grades. The illustrations show assessment items for \#1, "temperature and humidity"; \#2, "particle count"; \#3, "microbial monitoring"; and \#4, "insect" performed in each room. Insects were also monitored in the corridor and workspace, laboratory, and in front of the CPF.](pone.0236600.g001){#pone.0236600.g001}

[Fig 1B](#pone.0236600.g001){ref-type="fig"} shows the schematic diagram of our CPF. Operators entered from the entrance, went through the first gowning room, the buffer room, and the second gowning room in that order, entered the cell-processing room, and worked using a safety cabinet. The operators then passed through the second de-gowning room, the buffer room, and the first de-gowning room before exiting.

In this study, in front of the facility, the corridor and workspace outside the CPF, and the laboratory outside the CPF were considered the GE. The entrance of the CPF was labeled Grade D; the first gowning room, the buffer room, and the supply room were labeled Grade C; the second gowning room and cell-processing room were labeled Grade B; and the space in the safety cabinet was labeled Grade A.

Data collection {#sec004}
---------------

Assessment items were collected from January 2018 to December 2018. The data in the CPF during a certain period in February and March were not collected due to calibration and validation of the CPF for an annual inspection. The total number of entrance times in a month was counted based on the cell-processing record.

Monitoring of temperature and humidity {#sec005}
--------------------------------------

The temperature and humidity in each area were measured using the precision hair hygrothermometer (Higest II: Sato Keiryoki Mfg. Co., Ltd., Tokyo, Japan). The temperature outside the building was based on the database of the Japan Meteorological Agency. The mean values of temperature and humidity in the Grade D, Grade C, and Grade B areas were calculated from data automatically measured every 10 minutes (TH-EV6A, Shinyei Technology Co., Ltd., Kobe, Japan).

Monitoring of particles {#sec006}
-----------------------

The number of particles (≥ 0.5 μm) per m^3^ was manually obtained using METONE HHPC 3+ (Beckman Coulter, Inc., CA, USA) every two weeks. The maximum value was used. The integrated number of particles (≥ 5μm) was also obtained only in Grade B every 10 minutes using an automatic device (KA-02, Rion Co., Ltd., Tokyo, Japan). The data in cleanliness-controlled areas were shown as the maximum value in each room. Obtained data were divided in operation (during processing) and at rest (not during operation). Pearson's correlation coefficient between the number of entrance times to Grade B and the integrated number of particles in Grade B at all times including in operation and at rest was further analyzed.

Monitoring of microorganisms {#sec007}
----------------------------

One thousand L of air was aspirated by Biosamp (Midori Anzen Co., Ltd., Tokyo, Japan), and airborne microorganisms were cultured on soybean-casein digest agar (Becton, Dickinson and Company, NJ, USA). After five days of culture, macroscopic images of colonies were captured by M165 FC (Leica Microsystems GmbH, Wetzlar, Germany). In addition, settle plate and glove print tests were performed using a soybean-casein digest agar to assess the presence of microorganisms in Grade A. The quantification of colonies was visually evaluated after five days. The data in cleanliness-controlled areas were shown as the maximum value in each room. The chi-square test was performed to assess the association between humidity and the number of airborne microorganisms in Grade C and Grade D (test number = 133). An odds ratio was calculated for the rate of the occurrence of airborne microorganisms.

Identification of bacterial and fungus species {#sec008}
----------------------------------------------

Colonies of microorganisms were manually picked up and their nucleic acid extracted using a DNA extracting kit (QIAamp DNA mini kit, Qiagen, Venlo, Netherlands). Nucleic acids were amplified by PCR using a bacterial ribosomal RNA-specific designed primer and probe set \[[@pone.0236600.ref012]\]. Real-time PCR was performed in a LightCycler 480 instrument (Roche Diagnostics, Basel, Switzerland). For PCR reaction, the following reagents were used: forward primer; aggcagcagtDRggaat reverse primer; ggactacYVgggtatctaat probe FAM-tgccagcagccgcggtaatacRDag-BHQ and the LightCycler 480 Probes Master (Roche Diagnostics). DRYV in the sequence of primer and probe represents mixed bases defined by the International Union of Pure and Applied Chemistry. The PCR products were directly sequenced with Applied Biosystems 3130xl Genetic Analyzer (Thermo Fisher Scientific, Waltham, MA, USA). Bacterial and fungus species were identified by querying NCBI Nucleotide BLAST sequence data \[[@pone.0236600.ref013]\]. The species suggested by BLAST with an identified rate over 99% was considered a candidate species.

Monitoring of harmful insects {#sec009}
-----------------------------

Traps (Earth Environmental Service Co., Ltd., Osaka, Japan) were settled in each area. After 31 ± 7 days, the number of insects per trap was counted, and the species were identified macroscopically or using a stereo microscope. The number of insects per trap in the corridor outside the CPF was compared below 15°C and 15°C or more outside the building by the Mann Whitney U-test.

Cell processing and sterility test {#sec010}
----------------------------------

For clinical research "intraarticular injections of synovial stem cells for osteoarthritis of the knee" (UMIN000026732), cell products were prepared in the CPF. Detailed processing protocols have been reported previously \[[@pone.0236600.ref004]\]. Briefly, synovium was treated with enzyme and cultured in a medium containing autologous serum and antibiotics for 14 days. Twenty million cells were administered intraarticularly. According to the regulations of Japanese Pharmacopoeia, part of the cell products was subjected to a sterility test using fluid thioglycolate medium (Becton, Dickinson and Company) and soybean-casein digest broth (Becton, Dickinson and Company). These media were incubated at 22.5 ± 2.5°C and 32.5 ± 2.5°C, respectively. After 14 days, the presence or absence of microorganisms was visually evaluated.

Ethics approval and consent to participate {#sec011}
------------------------------------------

This clinical study (RM2018-006) was approved by the certified special committee for regenerative medicine in Tokyo Medical and Dental University (committee reference number: NA8140003) and submits a plan to the Minister of Health, Labor, and Welfare (MHLW, PB3160032). This clinical study was carried out in accordance with the Helsinki Declaration.

Statistical analysis {#sec012}
--------------------

All statistical analysis was performed with Prism 8 software (GraphPad Inc., La Jolla, CA, USA). Each statistical analysis is described in the material and methods section and figure legends. Two-tailed p values smaller than 0.05 were considered statistically significant.

Results {#sec013}
=======

Monitoring of temperature, humidity, and number of particles {#sec014}
------------------------------------------------------------

Although the temperature outside the building changed with seasons, that in the CPF was constant throughout the year ([Fig 2](#pone.0236600.g002){ref-type="fig"}). The temperature in Grade B and Grade C was always a few degrees lower than that in Grade D. The humidity in Grade B--D varied largely depending on that outside the building with highs in summer and lows in winter.

![Monthly transitions of temperature and humidity.\
The temperature outside the building is based on the database of the Japan Meteorological Agency. The data in cleanliness-controlled areas are shown as the average values of each measurement point.](pone.0236600.g002){#pone.0236600.g002}

Monitoring of particles {#sec015}
-----------------------

Monthly transitions in the number of particles (**≥** 0.5μm) differed from Grade B--D ([Fig 3A](#pone.0236600.g003){ref-type="fig"}). In Grade A, the particle number was almost zero except for February, when it was not measured. The number of particles was well below the acceptable limit, which was under 3,520 for Grade A and B, 35,200 for Grade C, and 3.52 million for Grade D. The integrated number of particles (**≥** 0.5μm) in Grade B correlated with the integrated number of entries to the cell-processing room ([Fig 3B](#pone.0236600.g003){ref-type="fig"}, R = 0.68, p = 0.03). The integrated number of particles (**≥** 5μm) in Grade B was also correlated with the integrated number of entries to the cell-processing room ([S1 Fig](#pone.0236600.s001){ref-type="supplementary-material"}, R = 0.64, p = 0.048).

![Monthly transitions in the number of particles per room and the relationship between this and the number of entries to the cell-processing room.\
(a) Monthly changes in the number of particles (≥ 0.5μm) in the room classified by each cleanliness level. The data in cleanliness-controlled areas were shown as the maximum value in each room. The dotted line indicates the acceptable limit for each room classified at each cleanliness level. (b) Relationship between integrated number of entries to the cell-processing room (Grade B) and integrated number of particles in the cell-processing room (Grade B). p = 0.03 by Pearson's correlation coefficient (R = 0.68). NA: not applicable.](pone.0236600.g003){#pone.0236600.g003}

Monitoring of microorganisms and identification of species {#sec016}
----------------------------------------------------------

Monthly transitions of the colony number of airborne microorganisms differed from Grade B--D ([Fig 4A](#pone.0236600.g004){ref-type="fig"}). In Grade A, the colony number was completely zero except for February, when it was not measured ([Fig 4B](#pone.0236600.g004){ref-type="fig"}). The number of colonies was well below the acceptable limit, which was under \<1 for Grade A, 10 for Grade B and 100 for Grade C and D. The entrance times into Grade B did not correlate with the number of airborne microorganisms ([S2 Fig](#pone.0236600.s002){ref-type="supplementary-material"}). PCR products from the colonies were sequenced directly, and seven bacteria, including four gram-negative and two gram-positive bacteria, along with two fungi, were identified ([S2 Table](#pone.0236600.s005){ref-type="supplementary-material"}). The gross appearance of the colonies varied in color, morphology, and size ([Fig 4C](#pone.0236600.g004){ref-type="fig"}). Positive colony detection rates were significantly higher at 55% or higher humidity with an odds ratio of 2.47 ([Fig 4D](#pone.0236600.g004){ref-type="fig"}).

![Monitoring of microorganisms and identification of species.\
(a) Monthly transition of colony number of airborne bacteria and fungi. Settle plate and glove print tests were also performed by using a soybean-casein digest agar in the Grade A area. The data in cleanliness-controlled areas were shown as the maximum value in each room. The dotted line indicates the allowable reference value in each room classified by each cleanliness level. NA: not applicable. (b) Monthly transition in falling bacteria and bacteria attached to gloves. (c) Representative colonies of detected airborne bacteria and fungus in soybean-casein digest agar. (d) Relationship between humidity and colony detection rate. The number of tests and the number of tests in which positive colonies were detected are shown for humidity of 55% or more and humidity less than 55%. p = 0.038 by the chi-square test.](pone.0236600.g004){#pone.0236600.g004}

Monitoring of harmful insects {#sec017}
-----------------------------

The total number of harmful insects per trap in one year shows that the majority were trapped in the corridor outside the CPF ([Fig 5A](#pone.0236600.g005){ref-type="fig"}). The total number of harmful insects per trap peaked in the corridor outside the CPF in April and August and in the laboratory outside the CPF in August ([Fig 5B](#pone.0236600.g005){ref-type="fig"}). The total number of insects per trap in the corridor outside the CPF was significantly increased when temperature outside the building was higher than 15°C ([S3 Fig](#pone.0236600.s003){ref-type="supplementary-material"}). Even in controlled areas, a small number of insects was constantly trapped between April and December ([Fig 5B](#pone.0236600.g005){ref-type="fig"}). Of the total number of insects trapped, the representative six species accounted for 92% ([Fig 5C and 5D](#pone.0236600.g005){ref-type="fig"}). The species of trapped insects varied by area, and the peaks of their numbers varied by the seasons ([Fig 5E and 5F](#pone.0236600.g005){ref-type="fig"}). *Psocoptera* accounted for 41.1% and peaked in August, and only Socoptera was trapped in Grade B. *Acari* accounted for 40.9% and peaked in April, and they were trapped during summer in all the areas except for Grade B. *Araneae*, *Collembola*, *Psychodidae*, and *Blattidae* accounted for 2--3% each. The others consisted of various species, such as *Hermann* ([Fig 5D](#pone.0236600.g005){ref-type="fig"}).

![Monitoring of harmful insects.\
(a) Total number of insects in one year per trap. (b) Monthly transition of insects trapped outside or inside the CPF. The number of insects is shown as maxima per trap for each month. Left y-axis indicates the number of insects per trap in the corridor outside the CPF. Right y-axis indicates the number of insects per trap in the laboratory outside the CPF. (c) Breakdown of trapped insects. One dot represents 1%. (d) Representative macroscopic images of the trapped insects. (e) Breakdown of trapped insects by room. (f) Heat map for monthly transitions of each representative insect per trap in each room. GE: general environment. Cor: corridor and workspace outside the CPF. Labo: laboratory outside the CPF. Front: in front of the cell-processing facility outside the CPF. Grade D: entrance. Grade C: first gowning room, buffer room, supply room, and de-gowning room. Grade B: second gowning room and cell-processing room. ND: not detected. NA: not applicable.](pone.0236600.g005){#pone.0236600.g005}

Cell production and sterility {#sec018}
-----------------------------

In the one year we assessed, six cell products for transplantation were cultured in this CPF. Their sterilities were guaranteed by the sterility test ([S3 Table](#pone.0236600.s006){ref-type="supplementary-material"}).

Discussion {#sec019}
==========

Although cell products cannot be sterilized, their sterility must be ensured for patient safety. To achieve the sterility of cell products, elimination of the risk of extrinsic contamination during the process is necessary. The assessment of environmental risk factors inside and outside CPFs will be effective to eliminate the contamination. However, these risk factors fluctuate depending on the season, CPF location, and human intervention. In the present study, we assessed environmental factors in a CPF and its adjacent GE throughout the year. Their effects on the sterility of cell products were also assessed. Our data suggested that various environmental factors could be a risk to the safety of cell products, and some of the factors interacted with each other, such as the relationship between humidity and colony number of airborne bacteria/fungi.

The cleanliness-controlled area in our CPF was maintained at a constant temperature, but the humidity fluctuated by the season. The equipment for humidity control is expensive and usually not set up in academic institutions. However, high humidity is usually the most influential factor for the growth of bacteria, fungi, and harmful insects \[[@pone.0236600.ref014]--[@pone.0236600.ref016]\]. In the present study, positive colony detection rates for bacteria and fungus from airborne microorganisms were significantly higher at humidity of 55% or higher. The fungi identified in this study, such as *Irpex lacteus*, are known to grow faster under humid conditions \[[@pone.0236600.ref014]\], and their proliferation could affect other factors, such as the number of *Psocoptera* that feed on fungi \[[@pone.0236600.ref015], [@pone.0236600.ref017]\]. Therefore, high humidity could be a major threat to the safety of cell products, and the control of humidity is an important issue for CPF management. It may thus be a solution to introduce a simple, temporal humidity control device in humid seasons.

In this study, the number of particles (**≥** 0.5μm) was within the acceptable range in all cleanliness-controlled areas throughout the year. Depending on the number of entrances made, the integrated number of particles in Grade B increased; however, the number of entries to the cell-processing room (Grade B) did not directly increase the number of airborne microorganisms. The particles in clean rooms have been reported to be dust from clothes or human skin flakes \[[@pone.0236600.ref018]\]. In addition, most microorganisms attach to dusts, skin flakes, and water droplets \[[@pone.0236600.ref018]\]. Ten to 1,000 suspended aerosol particles are considered to contain one microorganism \[[@pone.0236600.ref019], [@pone.0236600.ref020]\]. One report demonstrated that the number of particles correlated with that of airborne microorganisms in an operating theater and an ICU \[[@pone.0236600.ref021], [@pone.0236600.ref022]\]. On the other hand, some studies have reported that the number of particles do not correlate with the number of microorganisms \[[@pone.0236600.ref023]--[@pone.0236600.ref025]\]. Our results support the latter finding. Nevertheless, during the processing of clinical cell products, it will be essential to minimize the number of entries.

Environmental microorganisms were found in the humid season in Grade D, Grade C, and Grade B but were not detected in Grade A. The detection of environmental microorganisms is important to risk management in CPFs. For example, the generation of airborne microorganisms in controlled areas could occur due to structural problems in CPFs associated with outdoor inflow and human problems caused by carrying in materials. Therefore, the need for the identification of microorganisms is described in pharmacopoeias such as Japanese Pharmacopoeia, European Pharmacopoeia, and United States Pharmacopoeia. The microorganisms isolated in this study were reported to live in the GE \[[@pone.0236600.ref026]--[@pone.0236600.ref028]\]. However, there were multiple candidate species from BLAST, and they had still not been identified as one species. Our results showed that the gross appearance of the colonies varied in color, morphology, and size, which might be useful for the estimation of species to decide countermeasures against them. When the same colonies are detected, it will be easy to determine the cause and appropriate countermeasure. On the other hand, when the colonies are newly detected, the proper countermeasures, such as identification of species, consideration of possible causes, and selection of the optimal disinfection methods, are needed. The characteristics of each species (bacterium or fungi, resistance to disinfectants, high or low growth rate, etc.) is useful for CPF management policy.

We monitored microorganisms and identified seven bacteria, including four gram-negative bacteria and two gram-positive bacteria. *Sphingomonas paucimobilis*, which lives widely in the environment, is a highly adaptable bacteria that was once recognized in a spacecraft meal \[[@pone.0236600.ref029], [@pone.0236600.ref030]\]. *Ralstonia pickettii* \[[@pone.0236600.ref031]\] and *Burkholderia lata* \[[@pone.0236600.ref032]\] have been reported to live in chlorhexidine disinfectant and are harmful environmental bacteria. *Moraxella osloensis*\[[@pone.0236600.ref033]\] is known as an upper respiratory tract--resident bacteria. This bacterium is a major environmental microorganisms, producing 4-methyl-3-hexenoic acid (4M3H), which is a cause of malodor. *Methylobacterium suomiense* was recognized in small colonies in our study. A single detection of *Methylobacterium suomiense* is unlikely to be an environmental risk because of their low growth rates. However, they are resistant to chlorine in tap water and surfactants, resulting in the continuous and widespread detection of them even after treatment with usual disinfection alone. To disinfect them, hot water at 65°C or higher is necessary \[[@pone.0236600.ref034]\]. *Staphylococcus hominis* \[[@pone.0236600.ref035]\], one of the gram-positive bacteria, is also reported to be important as a nosocomial pathogen. Micrococcus yunnanensis \[[@pone.0236600.ref036]\] was isolated as environmental bacteria.

We also identified two fungi in the CPF: *Cladosporium cladosporioides*, which has been reported as a cause of sick building syndrome \[[@pone.0236600.ref037]\], and *Cladosporium cladosporioides*, which attaches to air conditioners \[[@pone.0236600.ref038]\] and present in the environment for a long time. If isolated multiple times in CPFs, the decontamination of the entire CPF will be required. *Irpex lacteus* \[[@pone.0236600.ref039]\] is a white rot fungus distributed in the environment, such as in dead broadleaf trees. Knowing these characteristics of detected microorganisms makes it possible to infer their entry routes into CPFs and to plan disinfection strategies.

Isolated species in the present study were known to have various origins and to inhabit, not only the environment, but also human skin \[[@pone.0236600.ref010], [@pone.0236600.ref040]\]. In fact, microorganisms derived from human skin were detected in stem cell banks in Spain \[[@pone.0236600.ref041]\]. In addition, Sandle et al. reported 6,729 isolated colonies of the bacteria in the Grade A and B clean areas \[[@pone.0236600.ref042]\]. In their review paper, the colonies of *Micrococcus* and *Staphylococcus*, skin resident bacteria, were detected most commonly, accounting for 50% of total colonies. The second-most common genera were species of *Bacillus*, an environmental bacterium, accounting for 13%. However, other reports have demonstrated types of detected microorganisms to be rich in variety \[[@pone.0236600.ref043]--[@pone.0236600.ref045]\]. The different microbiome may result from the difference in climate and processing products. In a humid environment, such as in Singapore, various microorganisms tend to be detected \[[@pone.0236600.ref046]\]. Resistant bacteria have also been found in antibiotic-producing facilities \[[@pone.0236600.ref011], [@pone.0236600.ref047]\]. To maintain CPFs properly, facility-specific evaluations based on local climatic characteristic and the processing products are very important.

In the corridor outside the CPF, many harmful insects were trapped in spring, summer, and autumn. Though on a smaller scale, similar results were found within the CPF. Such seasonal variability is useful for predicting insect number within the CPF. Insect intrusions into clean areas are known to be caused by humans or by decrepit facilities \[[@pone.0236600.ref048]\]. Since our CPF has been completed for fewer than five years, it is highly probable that insect invasion was accompanied by the movement of humans and materials. *Psocoptera*, commonly known as booklice \[[@pone.0236600.ref049]\], adhere to cardboard and clothes. *Psocoptera* were not trapped in Grade D or Grade C but in Grade B; it is thus highly likely that they were brought in with construction materials. Insect intrusion into a CPF may contaminate cell products because many harmful microorganisms attach to them \[[@pone.0236600.ref050]--[@pone.0236600.ref052]\]. Therefore, it will be important to periodically assess the number and characteristics of intruding insects, which can be affected by the number of entrance times, the age of the CPF, and appropriate feedback on risk management policy.

Though bacteria, fungi, and insects were detected in Grade B--D, no contamination was detected in the cell products during this study. One reason may be that bacteria, fungi, or insects were not detected in Grade A. Even if contamination occurs in the cell products, microorganisms can be detected by a sterility test of the cell products. Although this study focused on environmental factors, management of the entire process, including the detection of contamination and assurance of quality, is also important to realize the safety of cell products.

We faced three limitations in this study. First, larger particles (≥ 10 or 20 μm) were not evaluated because our CPF was completed only five years ago and we thought that there was no deterioration of the building. Measurement of large particles is considered useful for the detection of building deterioration \[[@pone.0236600.ref021], [@pone.0236600.ref022]\]. Second, the difference of the distribution of microorganisms by season and room was not fully analyzed. If microorganisms are brought in from the outside by clothes, improving the buffer room can be a countermeasure. If they are derived from human skin, changing clean room clothing or modifying entrance procedures may be useful. For them, more detailed analysis of the distribution of microorganism species in multiple rooms will be needed. Third, the classification of room cleanliness did not follow ISO standards or the Japanese Pharmacopoeia. In Japan, regenerative medicine using cell products is regulated by two laws: the Pharmaceuticals, Medical Devices and Other Therapeutic Products Act and the Act on the Safety of Regenerative Medicine (Safety Act), which are applied in the field of medical care and clinical research, respectively \[[@pone.0236600.ref006], [@pone.0236600.ref007]\]. Our clinical study was performed using Safety Act standards, not ISO or Pharmacopoeia standards.

In conclusion, this study assessed many environmental risks inside and outside a CPF throughout the year. Environmental factors varied with the seasons. The temperature in the CPF was constant, but the humidity fluctuated greatly depending on the season. The number of particles correlated with the number of entrance times. Various microorganisms were identified in the CPF, and high humidity increased their occurrence ratio. The types of trapped insects varied by CPF area. More insects were trapped in the season when outside temperature was higher than 15°C. Although many risks were found in the environment around the CPF, the sterility of the aseptic operation area and processed cells was maintained. These results provide useful data for taking the appropriate steps to keep entire CPFs clean.

Supporting information {#sec020}
======================

###### Relationship between integrated number of entries to the cell-processing room (Grade B) and integrated number of particles (≥ 5μm) in the cell-processing room (Grade B).

p = 0.048 by Pearson's correlation coefficient (R = 0.64). NA: not assigned.

(PDF)
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Click here for additional data file.

###### The number of airborne microorganisms and entrance times to the cell-processing room (Grade B).

(PDF)

###### 

Click here for additional data file.

###### The effect of temperature outside the building on the total number of insects per trap in the corridor outside the CPF.

Data are shown by median with interquartile range. p values were calculated by the Mann Whitney U-test.

(PDF)

###### 

Click here for additional data file.

###### Environment definition.

(PDF)

###### 

Click here for additional data file.

###### Sequence data of identified bacterium.

(PDF)

###### 

Click here for additional data file.

###### Sterility in cell processing products.

(PDF)

###### 

Click here for additional data file.
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3\. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: This manuscript is well written, with a clear and concise study design. The findings provide a detailed insight into the environmental risk factors associated with sterility of cell-processing facilities. The methodology for this study is clearly explained. The recommendations to mitigate environmental risks are made clear in the discussion of this study. The authors clarify the importance and impact of this study to influence CPF management policy to ensure cell-product quality. It is a reassuring study to highlight that while all products were produced aseptically and maintained sterility, further precautions are being taken to maintain the high quality procedures in CPFs.

Page 7, line 5 - "below 14 and above 15" -- rephrase to include 14-15°C

Page 7, line 16 - "Absence of pathogens" -- "rephrase to presence or absence"

"The number of particles was well below the acceptable limit for each room classified at each cleanliness level" -- state, unclear

"The number of colonies was well below the acceptable limit for each room classified at each cleanliness level" -- while these values are given in the figures and outlined in supplementary, it would be helpful to include in the text also for reference.

Figures are correctly labelled and clearly displayed.

Figure 5. The breakdown of trapped insects is unclear (e + f). Inside CPF in (e) states Psocoptera was found in B but (f) fails to highlight this finding. Same is true for D,C and B throughout.

Reviewer \#2: The authors of the current research manuscript have summarized the environmental risk assessment of cell-processing facilities (CPF) for cell therapy in Japanese academic institution. They have mainly presented the methods for monitoring the temperature, humidity, particle number, colony number of microorganisms, bacteria, fungi, and harmful insects in and around CPF monthly over one year and is well written. Figures are clear and properly labelled. Figure legends are appropriate and well written. Overall, the manuscript is well written and major areas on the appropriate steps to keep entire CPFs clean are covered. The manuscript is authoritative. This study has clearly demonstrated the importance of the safety of cell products and environmental risk factors with ongoing clinical study and it is reassuring. However, there are some minor improvements are required before accepting the manuscript for publication.

Minor Comments:

1\. Keep the 'P' letter used for statistical analysis constant, e.g. Method section: Statistical analysis and supplementary figure 3

2\. Page 20, Line 3: The size of integrated number of particles is mentioned '\> 0.5 µm' however rest everywhere it is '≥ 0.5 µm'. Please rectify this.

3\. Please provide reference here: Page 3, Introduction section, 14th-16th line- "The risk of extrinsic contamination can be affected by the location of the CPF, the environment inside or outside the CPF, and the degree of human intervention during the process."

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0236600.r002

Author response to Decision Letter 0

5 Jul 2020

Manuscript No. PONE-D-20-15060

July 6, 2020

PLOS ONE

Academic Editor

Dear Dr. Raghvendra Bohara,

Thank you for your comments on June 24, 2019. The title of our manuscript is "The environmental risk assessment of cell-processing facilities for cell therapy in a Japanese academic institution." Based on the valuable comments provided by the two reviewers, we have rewritten the manuscript, revised three figures, and added one supplemental figure. We believe these revisions address the reviewers' comments and that the paper now meets the journal's publication standards. We would very much appreciate having the paper reconsidered for publication in PLOS ONE.

Additional Editor Comments:

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf>

and

<https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

Author's response:

We thank the editor for the detailed proofreading of this study. In the revised manuscript, we have addressed all the concerns raised regarding the original manuscript. We have ensured that all heading levels are clearly indicated in the manuscript text, and we have modified the names of the supplementary figures to S1 Figure, S2 Figure, etc.

2\. We note that you have included the phrase "data not shown" in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

Author's response:

We removed the sentence from the manuscript as follows:

Since our CPF has been completed for fewer than five years, it is highly probable that insect invasion was accompanied by the movement of humans and materials. Psocoptera, commonly known as booklice \[49\], adhere to cardboard and clothes. Psocoptera were not trapped in Grade D or Grade C but in Grade B; it is thus highly likely that they were brought in with construction materials.

3\. Your ethics statement must appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please also ensure that your ethics statement is included in your manuscript, as the ethics section of your online submission will not be published alongside your manuscript.

Author's response:

We added the following section to the manuscript:

Ethics approval and consent to participate

This clinical study (RM2018-006) was approved by the certified special committee for regenerative medicine at the Tokyo Medical and Dental University (committee reference number: NA8140003) and submitted a plan to the Minister of Health, Labor, and Welfare (MHLW, PB3160032). This clinical study complied with the Helsinki Declaration.

Reviewer \#1:

This manuscript is well written, with a clear and concise study design. The findings provide a detailed insight into the environmental risk factors associated with sterility of cell-processing facilities. The methodology for this study is clearly explained. The recommendations to mitigate environmental risks are made clear in the discussion of this study. The authors clarify the importance and impact of this study to influence CPF management policy to ensure cell-product quality. It is a reassuring study to highlight that while all products were produced aseptically and maintained sterility, further precautions are being taken to maintain the high quality procedures in CPFs.

Author's response:

We thank Reviewer \#1 for the thoughtful comments on this study. In this revised manuscript, we have addressed all the concerns raised regarding the original manuscript.

Page 7, line 5 - "below 14 and above 15" -- rephrase to include 14-15°C

Author's response: We rewrote the manuscript and S3 Figure as follows:

The number of insects per trap in the corridor outside the CPF was compared below 15 °C and 15 °C or more outside the building by the Mann Whitney U-test.

S3 Figure.

To address Reviewer \#1's comment, we noticed the mistake in Figure 4d and modified it as follows:

Page 7, line 16 - "Absence of pathogens" -- "rephrase to presence or absence"

Author's response:

The original sentence was "After 14 days, the absence of pathogens was visually evaluated." This sterility test cannot deny the existence of another pathogen-like virus, so we corrected the sentence as follows:

"After 14 days, the presence or absence of microorganisms was visually evaluated."

"The number of particles was well below the acceptable limit for each room classified at each cleanliness level" -- state, unclear

"The number of colonies was well below the acceptable limit for each room classified at each cleanliness level" -- while these values are given in the figures and outlined in supplementary, it would be helpful to include in the text also for reference.

Figures are correctly labelled and clearly displayed.

Author's response:

To address this comment, we modified the sentences in the Results section as follows:

"The number of particles was well below the acceptable limit, which was under 3,520 for grades A and B, 35,200 for grade C, and 3,520,000 for grade D."

"The number of colonies was well below the acceptable limit, which was under 1 for grade A, 10 for Grade B, and 100 for grades C and D."

Figure 5. The breakdown of trapped insects is unclear (e + f). Inside CPF in (e) states Psocoptera was found in B but (f) fails to highlight this finding. Same is true for D,C and B throughout.

Author's response:

We modified Figure 5f to improve the visibility of trapped insects as follows:

Figure 5f

Reviewer \#2: The authors of the current research manuscript have summarized the environmental risk assessment of cell-processing facilities (CPF) for cell therapy in Japanese academic institution. They have mainly presented the methods for monitoring the temperature, humidity, particle number, colony number of microorganisms, bacteria, fungi, and harmful insects in and around CPF monthly over one year and is well written. Figures are clear and properly labelled. Figure legends are appropriate and well written. Overall, the manuscript is well written and major areas on the appropriate steps to keep entire CPFs clean are covered. The manuscript is authoritative. This study has clearly demonstrated the importance of the safety of cell products and environmental risk factors with ongoing clinical study and it is reassuring. However, there are some minor improvements are required before accepting the manuscript for publication.

Authors' response:

We appreciate the meaningful, favorable comments by Reviewer \#2 on this study. In this revised manuscript, we have addressed all the concerns raised regarding the original manuscript.

Reviewer \#2 Minor Comments:

1\. Keep the 'P' letter used for statistical analysis constant, e.g. Method section: Statistical analysis and supplementary figure 3

Author's response:

We rewrote the manuscript, figures, and figure legends as follows:

Figure 4d

S3 Figure

Legend for Figure 3:

Monthly transitions in the number of particles per room and the relationship between this and the number of entries to the cell-processing room. (a) Monthly changes in the number of particles (\> 0.5 μm) in the room classified by cleanliness level. The data in cleanliness-controlled areas were shown as the maximum value in each room. The dotted line indicates the acceptable limit for each room classified at each cleanliness level. (b) Relationship between integrated number of entries to the cell-processing room (Grade B) and integrated number of particles in the cell-processing room (Grade B). p = 0.03 by Pearson's correlation coefficient (R = 0.68). NA: not applicable.

Legend for Figure 4:

Monitoring of microorganisms and identification of species. (a) Monthly transition of colony number of airborne bacteria and fungi. Settle plate and glove print tests were also performed using a soybean-casein digest agar in the Grade A area. The data in cleanliness-controlled areas were shown as the maximum value in each room. The dotted line indicates the allowable reference value in each room classified by cleanliness level. NA: not applicable. (b) Monthly transition in falling bacteria and bacteria attached to gloves. (c) Representative colonies of detected airborne bacteria and fungus in soybean-casein digest agar. (d) Relationship between humidity and colony detection rate. The number of tests and the number of tests in which positive colonies were detected are shown for humidity of 55% or more and less than 55%. p = 0.038 by the chi-square test.

Legend for S1 Figure:

Relationship between integrated number of entries to the cell-processing room (Grade B) and integrated number of particles (≥ 5μm) in the cell-processing room (Grade B). p = 0.048 by Pearson's correlation coefficient (R = 0.64). NA: not assigned.

Legend for S3 Figure:

The effect of temperature outside the building on the total number of insects per trap in the corridor outside the CPF. Data are shown by median with interquartile range. p values were calculated by the Mann Whitney U-test.

2\. Page 20, Line 3: The size of integrated number of particles is mentioned '\> 0.5 µm' however rest everywhere it is '≥ 0.5 µm'. Please rectify this.

Author's response:

We rewrote the legend for Figure 3 as follows:

Figure 3. Monthly transitions in the number of particles per room and the relationship between this and the number of entries to the cell-processing room. (a) Monthly changes in the number of particles (≥ 0.5 μm) in the room classified by cleanliness level. The data in cleanliness-controlled areas were shown as the maximum value in each room. The dotted line indicates the acceptable limit for each room classified at each cleanliness level. (b) Relationship between integrated number of entries to the cell-processing room (Grade B) and integrated number of particles in the cell-processing room (Grade B). p = 0.03 by Pearson's correlation coefficient (R = 0.68). NA: not applicable.

3\. Please provide reference here: Page 3, Introduction section, 14th-16th line- "The risk of extrinsic contamination can be affected by the location of the CPF, the environment inside or outside the CPF, and the degree of human intervention during the process."

Author's response:

We added two references and rewrote the lines in question as follows:

"The risk of extrinsic contamination can be affected by the location of the CPF, the environment inside or outside the CPF, and the degree of human intervention during the process \[10, 11\]."

\[10.\] Prussin AJ, Marr LC. Sources of airborne microorganisms in the built environment. Microbiome. 2015;3(1):78. Epub 2015/12/24. doi: 10.1186/s40168-015-0144-z. PubMed PMID: 26694197; PubMed Central PMCID: PMCPMC4688924.

This review article explains that sources of microbial bioaerosols in the built environment may include humans; pets; plants; plumbing systems; heating, ventilation, and air-conditioning systems; mold; resuspension of settled dust; and outdoor air.

\[11.\] Hamdy AM, El-Massry M, Kashef MT, Amin MA, Aziz RK. Toward the drug factory microbiome: Microbial community variations in antibiotic-producing clean rooms. OMICS: A Journal of Integrative Biology. 2018;22(2):133--44. Epub 2017/09/06. doi: 10.1089/omi.2017.0091. PubMed PMID: 28873001.

This research article reports that the microbial composition of a nonantibiotic drug product was highly affected by the use of water, environmental conditions during the production process, the presence of personnel, and the type of product.

Sincerely yours,

Ichiro Sekiya, MD, PhD

Director, Center for Stem Cell and Regenerative Medicine

Professor, Department of Applied Regenerative Medicine

Tokyo Medical and Dental University (TMDU)

1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan

Tel: +81-3-5803-4017, Fax: +81-3-5803-0192, E-mail: <sekiya.arm@tmd.ac.jp>
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The environmental risk assessment of cell-processing facilities for cell therapy in a Japanese academic institution

PONE-D-20-15060R1

Dear Dr. Sekiya,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Raghvendra Bohara

Academic Editor

PLOS ONE

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: All comments regarding the original submission have been addressed and the authors now present a robust manuscript.

Reviewer \#2: Accept

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No
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The environmental risk assessment of cell-processing facilities for cell therapy in a Japanese academic institution

Dear Dr. Sekiya:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Raghvendra Bohara

Academic Editor

PLOS ONE
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